KARBE FRANK
SEC insider (Form 3/4/5 filer). CIK 0001276700. Director at Phathom Pharmaceuticals, Inc. (PHAT) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on May 19, 2026. Located in SAN DIEGO, CA.
Companies KARBE FRANK has filed insider reports for
- Phathom Pharmaceuticals, Inc. (PHAT): Director
- Cidara Therapeutics, Inc. (CDTX): Officer, Chief Financial Officer
KARBE FRANK
CIK: 0001276700
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- May 19, 2026PHAT
Phathom Pharmaceuticals, Inc.
AwardDirect24.1K shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirect7.5K shares at avg. $221.50$1.7M - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirect43.1K shares- - Dec 10, 2025CDTX
Cidara Therapeutics, Inc.
Tax PaymentDirect7.3K shares at avg. $219.60$1.6M - Jun 3, 2025PHAT
Phathom Pharmaceuticals, Inc.
AwardDirect10.5K shares- - Feb 24, 2025CDTX
Cidara Therapeutics, Inc.
AwardDirect57.5K shares- - Dec 13, 2024PHAT
Phathom Pharmaceuticals, Inc.
PurchaseDirect12.5K shares at avg. $7.93$99K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 19, 2026 |  PHAT Phathom Pharmaceuticals, Inc. | Award | 24,122 | - | $0 | Direct |
| Jan 7, 2026 |  CDTX Cidara Therapeutics, Inc. | Disposition | 7,526 | $221.50 | $1,667,009 | Direct |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc. | Disposition | 43,125 | - | $0 | Direct |
| Dec 10, 2025 | CDTX Cidara Therapeutics, Inc. | Tax Payment | 7,290 | $219.60 | $1,600,884 | Direct |
| Jun 3, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Award | 10,500 | - | - | Direct |
| Feb 24, 2025 | CDTX Cidara Therapeutics, Inc. | Award | 57,500 | - | - | Direct |
| Dec 13, 2024 | PHAT Phathom Pharmaceuticals, Inc. | Purchase | 12,500 | $7.93 | $99,084 | Direct |
1-7 of 7 transactions